Suresh K. Agarwal, MD, FACS, FCCM, FCCP Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Agarwal earned his medical degree at the University of Pittsburgh and completed his general surgery residency at the Hospital of Saint Raphael in New Haven, CT. He then completed three fellowships in trauma surgery at Hartford Hospital, Hartford, CT, surgical critical care at University of Connecticut, Farmington, CT and thoracic surgery at University of Wisconsin Hospital and Clinics.
UW Health Clinics
UW School of Medicine and Public Health
|Department of Surgery|
Professional Certifications and Education
Surgical Critical Care
Trauma Surgery, Hartford Hospital, Hartford, CT
Surgical Critical Care, University of Connecticut, Farmington, CT
Thoracic Surgery, University of Wisconsin Hospital and Clinics, Madison, WI
Hospital of Saint Raphael, New Haven, CT
University of Pittsburgh School of Medicine, Pittsburgh, PA, 1995
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Programs & Conditions
- Acute Care Surgery
- Surgical Critical Care
- Trauma and Life Support Center (TLC)
Dr. Agarwal is the principal investigator on a multi-center National Institute of Trauma grant for acute lung injury. He also the principal investigator for an American Association for the Surgery of Trauma-funded study to develop a novel tool for chest wall stabilization.
Salem AH Dunbar M Agarwal SK .
Pharmacokinetics of venetoclax in patients with 17p deletion chronic lymphocytic leukemia. Anticancer Drugs. 2017 Sep;28(8):911-914
[PubMed ID: 28562380]
Acher AW Campbell-Flohr SA Brenny-Fitzpatrick M Leahy-Gross KM Fernandes-Taylor S Fisher AV Agarwal S Kind AJ Greenberg CC Carayon P Weber SM .
Improving Patient-Centered Transitional Care after Complex Abdominal Surgery. J Am Coll Surg. 2017 Aug;225(2):259-265
[PubMed ID: 28549765]
Mowery NT Bruns BR MacNew HG Agarwal S Enniss TM Khan M Guo WA Cannon JW Lissauer ME Duane TM Hildreth AN Pappas PA Gries LM Kaiser M Robinson BRH .
Surgical management of pancreatic necrosis: A practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2017 Aug;83(2):316-327
[PubMed ID: 28452889]
Shulzhenko N Zens T Beems M Haines K Agarwal SK .
Reply to: Threshold of number of rib fractures in elderly blunt trauma: A simple or complex matter of numbers? Surgery. 2017 Jul 11;
[PubMed ID: 28709647]
Agarwal SK Mangal N Menon RM Freise KJ Salem AH .
Response Rates as Predictors of Overall Survival: A Meta-Analysis of Acute Myeloid Leukemia Trials. J Cancer. 2017;8(9):1562-1567
[PubMed ID: 28775775]
Utter GH Schuster KM Miller PR Mowery NT Agarwal SK Jr Winchell RJ Crandall ML .
The Capacity of ICD-10-CM/PCS to Characterize Surgical Care. J Trauma Acute Care Surg. 2017 May 22;
[PubMed ID: 28538626]
Agarwal SK Salem AH Danilov AV Hu B Puvvada S Gutierrez M Chien D Lewis LD Wong SL .
Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma. Br J Clin Pharmacol. 2017 Apr;83(4):846-854
[PubMed ID: 27859472]
Salem AH Agarwal SK Dunbar M Enschede SL Humerickhouse RA Wong SL .
Pharmacokinetics of Venetoclax, a Novel BCL-2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma. J Clin Pharmacol. 2017 Apr;57(4):484-492
[PubMed ID: 27558232]
Shulzhenko NO Zens TJ Beems MV Jung HS O'Rourke AP Liepert AE Scarborough JE Agarwal SK .
Number of rib fractures thresholds independently predict worse outcomes in older patients with blunt trauma. Surgery. 2017 Apr;161(4):1083-1089
[PubMed ID: 27932031]
Salem AH Hu B Freise KJ Agarwal SK Sidhu DS Wong SL .
Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers. Clin Drug Investig. 2017 Mar;37(3):303-309
[PubMed ID: 27910036]
Liu H Michmerhuizen MJ Lao Y Wan K Salem AH Sawicki J Serby M Vaidyanathan S Wong SL Agarwal S Dunbar M Sydor J de Morais SM Lee AJ .
Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites. Drug Metab Dispos. 2017 Mar;45(3):294-305
[PubMed ID: 27993930]
Agarwal SK DiNardo CD Potluri J Dunbar M Kantarjian HM Humerickhouse RA Wong SL Menon RM Konopleva MY Salem AH .
Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments. Clin Ther. 2017 Feb;39(2):359-367
[PubMed ID: 28161120]
Haines KL Agarwal S .
Postoperative Pulmonary Complications-A Multifactorial Outcome. JAMA Surg. 2017 Feb 1;152(2):166-167
[PubMed ID: 27829075]
Seymour JF Ma S Brander DM Choi MY Barrientos J Davids MS Anderson MA Beaven AW Rosen ST Tam CS Prine B Agarwal SK Munasinghe W Zhu M Lash LL Desai M Cerri E Verdugo M Kim SY Humerickhouse RA Gordon GB Kipps TJ Roberts AW .
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study. Lancet Oncol. 2017 Feb;18(2):230-240
[PubMed ID: 28089635]
Hyman DA Saha S Nayar HS Doyle JF Agarwal SK Chaiet SR .
Patterns of Facial Fractures and Protective Device Use in Motor Vehicle Collisions From 2007 to 2012. JAMA Facial Plast Surg. 2016 Dec 1;18(6):455-461
[PubMed ID: 27441732]
Schmitz NS Krach LE Coles LD Mishra U Agarwal SK Cloyd JC Kriel RL .
A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics. PM R. 2016 Nov 17;
[PubMed ID: 27867020]
Salem AH Agarwal SK Dunbar M Nuthalapati S Chien D Freise KJ Wong SL .
Effect of Low- and High-Fat Meals on the Pharmacokinetics of Venetoclax, a Selective First-in-Class BCL-2 Inhibitor. J Clin Pharmacol. 2016 Nov;56(11):1355-1361
[PubMed ID: 27029823]
Agarwal SK Hu B Chien D Wong SL Salem AH .
Evaluation of Rifampin's Transporter Inhibitory and CYP3A Inductive Effects on the Pharmacokinetics of Venetoclax, a BCL-2 Inhibitor: Results of a Single- and Multiple-Dose Study. J Clin Pharmacol. 2016 Nov;56(11):1335-1343
[PubMed ID: 26953185]
McQuistion K Zens T Jung HS Beems M Leverson G Liepert A Scarborough J Agarwal S .
Insurance status and race affect treatment and outcome of traumatic brain injury. J Surg Res. 2016 Oct;205(2):261-271
[PubMed ID: 27664871]
Jones AK Freise KJ Agarwal SK Humerickhouse RA Wong SL Salem AH .
Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis. AAPS J. 2016 Sep;18(5):1192-202
[PubMed ID: 27233802]